BioSpace News Archive

Oxurion NV, a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with a clinical stage portfolio in retinal vascular disorders, announces in a planned succession, the promotion of Tom Graney, CFA from Chief Financial Officer to Chief Executive Officer of the company.

The global mice model market is expanding on account of the striking relevance of these models in performing biomedical research.

Transparency Market Research has published a new report titled ‘Dental Biomaterials Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ According to the report, the global dental biomaterials market was valued at over US$ 600.0 Mn in 2017.

Transparency Market Research (TMR) has published a new report titled, “Global Continuous Positive Airway Pressure (CPAP) Interface Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027”.

Rising demand from clinical and compounding labs for sterile vials will provide growth opportunities to manufacturers over the coming years

Memo Therapeutics AG, an innovator in the field of antibody discovery and development, announced that MTX-COVAB, its human-derived antibody against SARS-CoV-2, the virus that causes COVID-19, has shown efficacy against both the original virus as well as the UK variant.

Professor Akimichi Morita, Vice Director of Nagoya City University Hospital, will lead RepliCel’s Skin Rejuvenation Clinical Testing in Japan

Former Elanco Animal Health, Johnson & Johnson, Intuitive Surgical, and Enteromedics Business Development Executive Joins Team to Support Growth Opportunities

New Board to consult Managing Board and Supervisory Board on scientific developments to ensure QIAGEN remains at the cutting edge in the Life Sciences and Molecular Diagnostics

Adjournment Solely to Vote on the Reverse Split and Proportional Authorized Shares Reduction Proposal (Proposal 2) and Increase in Authorized Shares Proposal (Proposal 3)